Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1

Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1

US Patent 11708415 · Granted Jul 25, 2023

Estimated economic value: $211,855,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) in2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of angiopoietin like 7 (ANGPTL7) related diseases2025
Treatment of sepsis with PCSK9 and LDLR modulators2025
Materials and methods of treating MHC-I-opathy risk haplotypes2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and method2025
Treatment of MST1 related diseases and disorders2025
Treatment of MST1 related diseases and disorders2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing 2025
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing 2025